InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Hawkinson Russ, Président. Director active across 1 companies, notably Silverback Therapeutics, Inc.. Cumulatively, 4 filings have been recorded. Total volume traded: €3k. The latest transaction was filed on 2 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
028,335 shares0
Common Stock
SEC:0001209191-22-027144:0·
€3,467200 shares@ €17.3366100.0% of flow
Common Stock
SEC:0001209191-22-012878:0·
Ideal exit: 4 Sept 2021 (T+270)
07,500 shares0
Common Stock
SEC:0001209191-22-006444:0·
07,500 shares0
Common Stock
SEC:0001209191-22-006444·
4 of 4 declarations
About Hawkinson Russ
Russ Hawkinson is the President of Silverback Therapeutics, Inc. He oversees the company's operations in the biotechnology field. His leadership is crucial for the ongoing innovation and growth of Silverback Therapeutics.
